Nicholas MBA - Agra Ventures Interim Director
| AGFAF Stock | USD 0.02 0.0009 6.16% |
Insider
Nicholas MBA is Interim Director of Agra Ventures
| Age | 43 |
| Phone | 800 783 6056 |
| Web | https://agraventures.com |
Agra Ventures Management Efficiency
The company has return on total asset (ROA) of (0.0411) % which means that it has lost $0.0411 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2886) %, meaning that it generated substantial loss on money invested by shareholders. Agra Ventures' management efficiency ratios could be used to measure how well Agra Ventures manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Baldyga | Biofrontera | N/A | |
| Jeff Holm | Biofrontera | N/A | |
| David Erickson | Evolus Inc | N/A | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| BComm BCom | Akanda Corp | 68 | |
| OriMoni Mimon | INC Research Holdings | 36 | |
| John Weston | cbdMD Inc | N/A | |
| Eugene III | Biofrontera | 39 | |
| Kevin MacDermott | cbdMD Inc | 62 | |
| Amos Cohen | INC Research Holdings | 45 | |
| BCom BAcc | Akanda Corp | 44 | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Raymond Coffman | cbdMD Inc | 62 | |
| Sibyl Swift | cbdMD Inc | 43 | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Sandra Beaver | Evolus Inc | 46 | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Erica CPA | Biofrontera | 39 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Thomas Flow | Akanda Corp | 46 | |
Management Performance
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0411 |
Agra Ventures Leadership Team
Elected by the shareholders, the Agra Ventures' board of directors comprises two types of representatives: Agra Ventures inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agra. The board's role is to monitor Agra Ventures' management team and ensure that shareholders' interests are well served. Agra Ventures' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agra Ventures' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Karroll, Director Marketing | ||
| Nicholas MBA, Interim Director | ||
| ACCA BA, CFO Director | ||
| Katrin Eckmans, MD GmbH | ||
| Zbigniew MSc, VP Exploration | ||
| Ruben Houweling, Head Growing | ||
| Elise Coppens, Consultant |
Agra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Agra Ventures a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0411 | |||
| Operating Margin | (4.34) % | |||
| Current Valuation | 13.6 M | |||
| Shares Outstanding | 107.62 M | |||
| Shares Owned By Insiders | 0.58 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 1.08 X | |||
| Revenue | 928.21 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Agra Pink Sheet
Agra Ventures financial ratios help investors to determine whether Agra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Agra with respect to the benefits of owning Agra Ventures security.